NCT04110691

Brief Summary

The goal of the study is to evaluate the Impact of coronary stent length and/or diameter in patients with ST segment myocardial infarction undergoing primary PCI, on Short term clinical outcomes.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 1, 2019

Completed
9 months until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 28, 2022

Completed
Last Updated

May 19, 2020

Status Verified

May 1, 2020

Enrollment Period

1.2 years

First QC Date

September 28, 2019

Last Update Submit

May 15, 2020

Conditions

ST-segment Elevation Myocardial Infarction (STEMI)

Outcome Measures

Primary Outcomes (1)

  • prognosis of patients with ST segment myocardial infarction undergoing primary PCI

    prognosis will be measured with ECG and ECHO

    3 months

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with ST segment elevation myocardial infarction undergoing primary PCI

You may qualify if:

  • Patients with ST segment myocardial infarction who are eligible for PCI.
  • All categories (all age groups and both sex groups)

You may not qualify if:

  • Patients with previous PCI.
  • Patients of ectatic lesions.
  • Patients with with multi vessel disease and suitable for CABG.
  • Patients with complex lesions including bifurcational lesions and LM stenting.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

ST Elevation Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Nada Deyaa

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Doaa Ahmed Fouad, Professor

CONTACT

01001085828fouaddoaa@yahoo.com

Ahmed Abdel Galeel, Assistant Professor

CONTACT

01005015156Ahmed_gelil@yahoo.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 28, 2019

First Posted

October 1, 2019

Study Start

July 1, 2020

Primary Completion

September 30, 2021

Study Completion

January 28, 2022

Last Updated

May 19, 2020

Record last verified: 2020-05